A study of clinical profile and factors associated with community acquired pneumonia at tertiary health care center

 

 

REFERENCES

1. Acharya VK, Padyana M, Unnikrishnan B, Anand R, Acharya PR, Juneja DJ. Microbiological profile and drug sensitivity pattern among community acquired pneumonia patients in tertiary care centre in Mangalore, Coastal Karnataka. Indian J Clin Diagn Res. 2014;8(6):MC04–MC06.
2. Giriraj B, Manthale D. Clinico-microbiological profile of community acquired pneumonia in a Tertiary care hospital. Journal of Biomedical and Pharmaceutical Research. 2015;4(4):65-68.
3. Community-acquired pneumonia: Bacterial profile and microbiological Investigations. Supplement to Journal of Association of Physicians of India. 2013;61:9-11.
4. Bansal S, Kashyap S. A clinical and bacteriological profile of community acquired pneumonia in Shimla, Himachal Pradesh. Indian Journal of Chest Diseases and Allied Sciences. 2004;46:17-22
5. Mandell LA, Wunderink R. Pneumonia. In: Fauci AS, Braunwald E, Kasper D, et al ed. Harrison’s principles of Internal Medicine. Volume 2. 17th edn. McGraw-Hill; 2008:1619-28.
6. Shah BA, Ahmed W, Dhobi GN, et al. Validity of Pneumonia Severity Index and CURB-65 severity scoring systems in Community acquired pneumonia in an Indian setting. Indian J Chest Dis Allied Sci 2010;52:9-17.
7. Murdroch DR, Woods CW, Zimmerman MD, et al. The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, Nepal. Am J Trop Med Hyg 2004;6:670-5.
8. Marston BJ, Plouffe JF, File TM, et al. Incidence of community aquired pneumonia requiring hospitalization. Arch Intern Med 1997;157:1709-18.
9. Mauricio R, Santiago E, Maria AM, et al. Etiology of Community acquired Pneumonia. Am J Resp Crit Care med 1999;160:2397-405
10. Almirall J, Bolibar I, Vidal J, et al. Epidemiology of community acquired pneumonia in adults: a population based study. Eur Respir J 2000;15:757-63.
11. Millett ER, De Stavola BL, Quint JK, Smeeth L, Thomas SL. Risk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort study. BMJ Open. 2015;5(12):e008737.
12. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171(3):242–248
13.  Gupta D, Agarwal R, Aggarwal AN, Singh N, Mishra N, Khilnani GC, et al. Guidelines for diagnosis and management of community‑ and hospital‑acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India 2012;29:S27‑62.
14. Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology and outcome of community‑acquired pneumonia in patients with diabetes mellitus. Chest 2005;128:3233‑9.
15.  Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: Implications for management guidelines. Thorax 2001;56:296‑301.